Market Rank #16 · Evidence Tier A

Sweden
Neuroscience Intelligence

Sweden neuroscience intelligence: 176 indexed trials, 31 institutions, research score 34.72.

⚗
176Indexed trials
↗
39Recruiting
⌂
31Research institutions
◎
34.7Research score

Evidence profile

73Sponsors
27Disease areas
0Institution works
0Institution citations

Model signals

Opportunity 35 · ML priority 35 · Confidence 85 · Evidence 34.7

These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.

Leading disease areas

alzheimers36trials
parkinsons16trials
adhd13trials
depression10trials
stroke10trials
other_psychiatry7trials
epilepsy7trials
anxiety7trials
other_neurology6trials
pain_neuropathy6trials

Leading indexed sponsors

Karolinska Institutet37trials
Hoffmann-La Roche7trials
Region Skane7trials
Göteborg University6trials
Merck Sharp & Dohme LLC6trials
Pfizer5trials
Uppsala University5trials
Sahlgrenska University Hospital5trials
Eli Lilly and Company4trials
Umeå University4trials